Literature DB >> 18948752

Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.

Ichiro Onoyama1, Keiichi I Nakayama.   

Abstract

Regulation of the exit of cells from the cell cycle is important in the development of multicellular organisms and is also implicated in the maintenance of stem cells. Furthermore, defects in cell cycle exit are thought to be a major cause of cancer. However, the mechanisms responsible for regulation of cell cycle exit have remained largely unknown. Fbxw7 is the F-box protein subunit of an SCF-type ubiquitin ligase complex that targets positive regulators of the cell cycle-including cyclin E, c-Myc, Notch and c-Jun-for ubiquitylation and subsequent degradation by the 26S proteasome in order to promote cell cycle exit. Consistent with such a function, mutations of the Fbxw7 gene have been detected in various human malignancies. We have recently generated conventional and conditional Fbxw7 knockout mice and examined stem cells, progenitor cells and differentiated cells in the mutant animals for cell cycle defects. Here we summarize the pleiotropic phenotypes of Fbxw7 deficiency in various cell types including T cells, hematopoietic stem cells and embryonic fibroblasts. Such phenotypes have provided insight into the biological roles of Fbxw7 in cell cycle exit, stem cell maintenance and oncosuppression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948752     DOI: 10.4161/cc.7.21.6931

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  21 in total

1.  Controlling stem cell fate one substrate at a time.

Authors:  Brian S Garrison; Derrick J Rossi
Journal:  Nat Immunol       Date:  2010-03       Impact factor: 25.606

2.  Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.

Authors:  Hideyuki Shimizu; Shoichiro Takeishi; Hirokazu Nakatsumi; Keiichi I Nakayama
Journal:  JCI Insight       Date:  2019-02-21

3.  MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling.

Authors:  Krasimira Rozenova; Jing Jiang; Ryan Donaghy; Bernadette Aressy; Roger A Greenberg; Wei Tong
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

4.  FBXW7 is involved in Aurora B degradation.

Authors:  Chieh-Lin Teng; Yun-Chi Hsieh; Liem Phan; Jihyun Shin; Chris Gully; Guermarie Velazquez-Torres; Stephen Skerl; Sai-Ching J Yeung; Shih-Lan Hsu; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

5.  HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53.

Authors:  Yuwen Xue; Jian Chen; Hyun-Ho Choi; Liem Phan; Ping-Chieh Chou; Ruiying Zhao; Huiling Yang; Janice Santiago; Mo Liu; Giselle E Yeung; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

6.  Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.

Authors:  Chen Tian; Guoguang Zheng; Zhipan Cao; Qiao Li; Zhenyu Ju; Jinhong Wang; Weiping Yuan; Tao Cheng
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

7.  A robust cell cycle control mechanism limits E2F-induced proliferation of terminally differentiated cells in vivo.

Authors:  Laura A Buttitta; Alexia J Katzaroff; Bruce A Edgar
Journal:  J Cell Biol       Date:  2010-06-14       Impact factor: 10.539

8.  Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.

Authors:  Emily B Askew; Suxia Bai; Andrew T Hnat; John T Minges; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2009-10-14       Impact factor: 5.157

9.  Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

Authors:  Elisabetta Kuhn; Ren-Chin Wu; Bin Guan; Gang Wu; Jinghui Zhang; Yue Wang; Lei Song; Xiguo Yuan; Lei Wei; Richard B S Roden; Kuan-Tin Kuo; Kentaro Nakayama; Blaise Clarke; Patricia Shaw; Narciso Olvera; Robert J Kurman; Douglas A Levine; Tian-Li Wang; Ie-Ming Shih
Journal:  J Natl Cancer Inst       Date:  2012-08-23       Impact factor: 13.506

10.  Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes.

Authors:  Dong Seok Kim; Wei Zhang; Scott E Millman; Byung Joon Hwang; Seok Joo Kwon; Carol Clayberger; Michele Pagano; Alan M Krensky
Journal:  Blood       Date:  2012-07-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.